Cedars-Sinai awarded $8 million to launch new stem cell clinic
Newswise — LOS ANGELES, Oct. 28, 2022 — Cedars-Sinai received an $8 million, five-year grant from California’s Stem Cell Agency to open a new innovative clinic. The clinic will increase patients’ access stem cell therapies and gene therapy, improve research and training on regenerative medicine and foster collaboration with other similar clinics in the state.
California Institute for Regenerative Medicine approved Cedars-Sinai’s plan to open an Alpha Stem Cell Clinic. This brings Cedars-Sinai in a network Alpha sites across California. Cedars-Sinai will conduct preclinical research into early and late phase clinical trials in order to establish advanced regenerative treatments for debilitating illnesses that are FDA-approved.
Cedars-Sinai’s initiative is led by the Cedars-Sinai Board of Governors Regenerative Medicine Institute, and the Smidt Heart Institute. The new Alpha Clinic is modeled after a Regenerative Medicine Clinic that was jointly operated at Cedars-Sinai and opened in 2014. This clinic expanded scientific discovery and clinical trial for neurological, cardiovascular and musculoskeletal diseases.